mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.3 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.3 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.3 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |